4.755
price down icon7.67%   -0.395
after-market Handel nachbörslich: 4.84 0.085 +1.79%
loading
Schlusskurs vom Vortag:
$5.15
Offen:
$5
24-Stunden-Volumen:
3.48M
Relative Volume:
2.67
Marktkapitalisierung:
$432.99M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-10.57
EPS:
-0.45
Netto-Cashflow:
$-24.91M
1W Leistung:
-15.99%
1M Leistung:
-3.94%
6M Leistung:
+35.09%
1J Leistung:
+197.19%
1-Tages-Spanne:
Value
$4.62
$5.12
1-Wochen-Bereich:
Value
$4.62
$5.80
52-Wochen-Spanne:
Value
$1.52
$6.23

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Firmenname
Aquestive Therapeutics Inc
Name
Telefon
908-941-1900
Name
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Mitarbeiter
135
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-18
Name
Neueste SEC-Einreichungen
Name
AQST's Discussions on Twitter

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2019-04-22 Eingeleitet H.C. Wainwright Buy
2019-01-03 Eingeleitet Lake Street Buy
2018-08-20 Eingeleitet JMP Securities Mkt Outperform
2018-08-20 Eingeleitet RBC Capital Mkts Outperform

Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten

pulisher
02:09 AM

Aquestive: Rare Opportunity With Dual Platform Strategy (NASDAQ:AQST) - Seeking Alpha

02:09 AM
pulisher
10:37 AM

Aquestive Therapeutics (NASDAQ:AQST) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

10:37 AM
pulisher
05:06 AM

Aquestive Therapeutics: Q3 Earnings Snapshot - mySA

05:06 AM
pulisher
Nov 04, 2024

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics reports Q3 EPS (13c), consensus (13c) - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

AQSTAquestive Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Optimistic Financial and Strategic Outlook - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 01, 2024

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need T - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $8.83 Consensus Target Price from Brokerages - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

Learn to Evaluate (AQST) using the Charts - Stock Traders Daily

Oct 29, 2024
pulisher
Oct 28, 2024

Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $13.00 - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

Aquestive Therapeutics (AQST) Set to Announce Quarterly Earnings on Monday - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Leerink raises Aquestive Therapeutics stock PT on 'top-line' study results - Investing.com Canada

Oct 26, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics to Present Subsequent Analysis of - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Leerink Partners Raises Aquestive Therapeutics (NASDAQ:AQST) Price Target to $13.00 - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics (NASDAQ:AQST) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$51m last week but individual investors profited the most - Simply Wall St

Oct 25, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics' SWOT analysis: stock poised for growth as Anaphylm nears FDA submission - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Pushes Retail Sentiment Into ‘Extremely Bullish’ Zone On OAS Drug Trial Success - Barchart

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics' SWOT analysis: stock poised for growth as Anaphylm nears FDA submission By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Inc (AQST) Has Recovered 74.67% From Its Low: Is This The Beginning Of A Trend? - Stocks Register

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Announces Positive Topline Results - GlobeNewswire

Oct 24, 2024
pulisher
Oct 22, 2024

Aquestive Therapeutics a new overweight at Piper on oral film products - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Aquestive Therapeutics to Report Third Quarter 2024 - GlobeNewswire

Oct 21, 2024
pulisher
Oct 16, 2024

Aquestive Therapeutics updates bylaws, shortens nomination look-back By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Aquestive Therapeutics updates bylaws, shortens nomination look-back - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

Investing in Aquestive Therapeutics Inc (AQST) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Financial Snapshot: Analyzing Aquestive Therapeutics Inc (AQST)’s Key Ratio Metrics - The Dwinnex

Oct 14, 2024
pulisher
Oct 09, 2024

Top investors say Aquestive Therapeutics Inc (AQST) ticks everything they need - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

Aquestive Therapeutics (NASDAQ:AQST) Given "Market Outperform" Rating at JMP Securities - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

In the Green: Aquestive Therapeutics Inc (AQST) Closes at 4.85, Up/Down -2.02 from Previous Day - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Should investors be concerned about Aquestive Therapeutics Inc (AQST)? - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $8.67 Average Price Target from Brokerages - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Position Trimmed by Renaissance Technologies LLC - MarketBeat

Oct 06, 2024
pulisher
Oct 02, 2024

A better buy-in window may exist right now for Aquestive Therapeutics Inc (AQST) - SETE News

Oct 02, 2024
pulisher
Oct 01, 2024

Can you now get a good deal on Aquestive Therapeutics Inc’s shares? - US Post News

Oct 01, 2024
pulisher
Sep 30, 2024

Aquestive Therapeutics stock target lifted, rating held on product pipeline By Investing.com - Investing.com Canada

Sep 30, 2024
pulisher
Sep 30, 2024

aquestiveinvestordayreca.htm - SEC.gov

Sep 30, 2024
pulisher
Sep 30, 2024

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - AOL

Sep 30, 2024
pulisher
Sep 30, 2024

Trading Day Review: Aquestive Therapeutics Inc (AQST) Loses Momentum, Closing at 4.72 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

AQST’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

Aquestive Therapeutics (NASDAQ:AQST) Earns "Market Outperform" Rating from JMP Securities - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $10.00 - MarketBeat

Sep 30, 2024
pulisher
Sep 28, 2024

146,155 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Purchased by Deerfield Management Company L.P. Series C - MarketBeat

Sep 28, 2024
pulisher
Sep 28, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewswire

Sep 28, 2024
pulisher
Sep 28, 2024

Aquestive advances epinephrine treatments, completes study By Investing.com - Investing.com South Africa

Sep 28, 2024

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aquestive Therapeutics Inc-Aktie (AQST) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schobel Alexander Mark
Chief Innovation/Tech Officer
Mar 08 '24
Sale
5.19
25,000
129,685
1,040,371
$12.67
price up icon 0.88%
$114.96
price down icon 0.42%
$89.24
price up icon 3.56%
$58.48
price down icon 0.36%
$121.53
price up icon 0.83%
$11.61
price up icon 1.40%
Kapitalisierung:     |  Volumen (24h):